BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1900445)

  • 1. Homeostatic action of interleukin-4 on endogenous and recombinant interleukin-2-induced activated killer cell function.
    Bello-Fernandez C; Bird C; Heslop HE; Gottlieb DJ; Reittie JE; Rill DM; Holland M; Prentice HG; Brenner MK
    Blood; 1991 Mar; 77(6):1283-9. PubMed ID: 1900445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-4 acts as a homeostatic regulator of IL-2-induced TNF and IFN-gamma.
    Bello-Fernandez C; Oblakowski P; Meager A; Duncombe AS; Rill DM; Hoffbrand AV; Brenner MK
    Immunology; 1991 Feb; 72(2):161-6. PubMed ID: 1901829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation.
    Heslop HE; Gottlieb DJ; Bianchi AC; Meager A; Prentice HG; Mehta AB; Hoffbrand AV; Brenner MK
    Blood; 1989 Sep; 74(4):1374-80. PubMed ID: 2504308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).
    Itoh K; Shiiba K; Shimizu Y; Suzuki R; Kumagai K
    J Immunol; 1985 May; 134(5):3124-9. PubMed ID: 2984283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of recombinant interferons with recombinant interleukin-2: differential effects on natural killer cell activity and interleukin-2-activated killer cells.
    Brunda MJ; Tarnowski D; Davatelis V
    Int J Cancer; 1986 May; 37(5):787-93. PubMed ID: 2422129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD3-activated killer T cells: interferon-gamma and interleukin-10 cross-regulate granzyme B expression and the induction of major histocompatibility complex-unrestricted cytotoxicity.
    Fitzpatrick L; Makrigiannis AP; Kaiser M; Hoskin DW
    J Interferon Cytokine Res; 1996 Jul; 16(7):537-46. PubMed ID: 8836920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells.
    Itoh K; Tilden AB; Kumagai K; Balch CM
    J Immunol; 1985 Feb; 134(2):802-7. PubMed ID: 3917475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors.
    Bosly A; Guillaume T; Brice P; Humblet Y; Staquet P; Doyen C; Chatelain B; Franks CR; Gisselbrecht C; Symann M
    Exp Hematol; 1992 Sep; 20(8):962-8. PubMed ID: 1354620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological monitoring of low-dose interleukin 2 in humans: soluble interleukin 2 receptors, cytokines, and cell surface phenotypes.
    Hänninen EL; Körfer A; Hadam M; Schneekloth C; Dallmann I; Menzel T; Kirchner H; Poliwoda H; Atzpodien J
    Cancer Res; 1991 Dec; 51(23 Pt 1):6312-6. PubMed ID: 1933892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of interleukin-12- and interleukin-15-induced natural killer cell activation by interleukin-4.
    Salvucci O; Mami-Chouaib F; Moreau JL; Thèze J; Chehimi J; Chouaib S
    Eur J Immunol; 1996 Nov; 26(11):2736-41. PubMed ID: 8921963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2-activated natural killer cells can support hematopoiesis in vitro and promote marrow engraftment in vivo.
    Murphy WJ; Keller JR; Harrison CL; Young HA; Longo DL
    Blood; 1992 Aug; 80(3):670-7. PubMed ID: 1379086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells.
    Gemlo BT; Palladino MA; Jaffe HS; Espevik TP; Rayner AA
    Cancer Res; 1988 Oct; 48(20):5864-7. PubMed ID: 3139285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CD3-activated killer T cells: Interleukin-6 modulates the induction of major histocompatibility complex-unrestricted cytotoxicity and the expression of genes coding for cytotoxic effector molecules.
    Greene AL; Makrigiannis AP; Fitzpatrick L; Hoskin DW
    J Interferon Cytokine Res; 1997 Dec; 17(12):727-37. PubMed ID: 9452360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells.
    Zambello R; Trentin L; Cerutti A; Enthammer C; Milani A; Franceschi T; Messina C; Cetto GL; Agostini C; Semenzato G
    Cancer; 1994 Nov; 74(9):2562-9. PubMed ID: 7522954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 matrix protein p17 enhances the proliferative activity of natural killer cells and increases their ability to secrete proinflammatory cytokines.
    Vitale M; Caruso A; De Francesco MA; Rodella L; Bozzo L; Garrafa E; Grassi M; Gobbi G; Cacchioli A; Fiorentini S
    Br J Haematol; 2003 Jan; 120(2):337-43. PubMed ID: 12542496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K; Varalakshmi C; Khar A
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the human immature natural killer cell subset by IL-12 and its regulation by endogenous TNF-alpha and IFN-gamma secretion.
    Jewett A; Bonavida B
    Cell Immunol; 1994 Apr; 154(1):273-86. PubMed ID: 7907529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of various cytokines with interleukin 2 in the generation of killer cells from human bone marrow: application in purging of leukemia.
    Charak BS; Agah R; Gray D; Mazumder A
    Leuk Res; 1991; 15(9):801-10. PubMed ID: 1921458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4 regulation of a protein kinase C independent pathway for the generation of alpha CD3-induced activated killer cells.
    Ting CC; Hargrove ME
    Cell Immunol; 1992 Mar; 140(1):130-44. PubMed ID: 1531452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphokine-activated effector cells: modulation of activity by cytokines.
    Mehta S; Flanagan P; Blackinton D; Wanebo H
    Lymphokine Cytokine Res; 1992 Apr; 11(2):73-7. PubMed ID: 1581419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.